Different effects of plasmids harboring bla(OXA-232) between major and minor clones in Klebsiella pneumoniae

携带 bla(OXA-232) 的质粒对肺炎克雷伯菌主要克隆和次要克隆的影响不同

阅读:1

Abstract

This study investigated the differing impact of introducing the globally reported bla(OXA-232)-harboring ColE-type plasmid on the plasmid stability, competitiveness, virulence, and gene expression of Klebsiella pneumoniae transconjugants from major high-risk genotypes (ST11, ST15, and ST307) compared to minor genotypes. Plasmid transformation was performed with electroporation. The carbapenem resistance, plasmid stability, competitive fitness, and virulence were assessed through antibiotic susceptibility profiling, plasmid stability, competition assay, human serum resistance assay, and quantitative real-time PCR. Consistent plasmid stability was evident across all genotypes and nutrient conditions tested following the introduction of the plasmid. K. pneumoniae transconjugants from major clones demonstrated increased competitiveness and virulence compared to their wild-type counterparts, while those from minor clones did not. Increased expression of the virulence-associated fimH gene was observed only in the transconjugants from the major clones. These results highlight a complex interplay between plasmids and bacterial hosts and explain why specific clones producing carbapenemase are frequently observed globally. IMPORTANCE: OXA-232 is a variant of OXA-48-like carbapenemase, exhibiting high hydrolytic activity against penicillin and weak activity against carbapenems. It was associated with widespread dissemination of carbapenem-resistant Enterobacteriaceae including Klebsiella pneumoniae. Particularly, it has been identified that high-risk clones (ST11 and ST15) of K. pneumoniae frequently harbor the plasmid with bla(OXA-232), that is, ColE-type plasmid. In this study, it is revealed that K. pneumoniae of high-risk clones with ColE-type plasmid harboring bla(OXA-232) showed an increase in competitiveness and virulence. It may explain why certain carbapenemase-producing clones are widespread worldwide, emphasizing the need to focus on coping with antibiotic resistance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。